What Does Wall Street See for Balchem's Q2?
Balchem (NAS: BCPC) is expected to report Q2 earnings on July 31. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Balchem's revenues will grow 9.9% and EPS will grow 18.2%.
The average estimate for revenue is $86.9 million. On the bottom line, the average EPS estimate is $0.39.
Last quarter, Balchem notched revenue of $84.7 million. GAAP reported sales were 11% higher than the prior-year quarter's $76.2 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, EPS came in at $0.36. GAAP EPS of $0.36 for Q1 were 16% higher than the prior-year quarter's $0.31 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 28.6%, 80 basis points better than the prior-year quarter. Operating margin was 18.7%, 80 basis points better than the prior-year quarter. Net margin was 12.9%, 70 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $343.9 million. The average EPS estimate is $1.53.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 341 members out of 349 rating the stock outperform, and eight members rating it underperform. Among 99 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 98 give Balchem a green thumbs-up, and one give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Balchem is outperform, with an average price target of $44.67.
The rich are different than you and me: They might not notice the moneymaking stories right under our noses. In our new report, "Middle-Class Millionaire-Makers: 3 Stocks Wall Street's Too Rich to Notice," we give you three Peter Lynch-inspired buy-what-you-know stocks for the 99%. Click here for instant access to this free report.
- Add Balchem to My Watchlist.
The article What Does Wall Street See for Balchem's Q2? originally appeared on Fool.com.Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor ofMotley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool recommends Balchem. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.